GM-CSF-induced CD11c+CD8a - Dendritic cells facilitate Foxp3+ and IL-10+ regulatory T cell expansion resulting in suppression of autoimmune thyroiditis

International Immunology

Volumn 21, Issue 3, 2009, Pages 269-282

  Ganesh, Balaji B ^a   Cheatem, Donald M ^a   Sheng, Jian Rong ^a   Vasu, Chenthamarakshan ^a   Prabhakar, Bellur S ^a  

^a UNIVERSITY OF ILLINOIS   (United States)

Author keywords

Autoimmunity; Dendritic cells; GM CSF; Regulatory T cells; Thyroiditis; Tolerance

Indexed keywords

B7 ANTIGEN; CD8ALPHA ANTIGEN; GLYCOPROTEIN P 15095; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 1BETA; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; RECOMBINANT GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; TRANSCRIPTION FACTOR FOXP3;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN EXPRESSION; ANTIGEN PRESENTATION; ARTICLE; AUTOIMMUNE THYROIDITIS; CELL EXPANSION; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DENDRITIC CELL; DRUG MECHANISM; FEMALE; IN VIVO STUDY; MOUSE; NONHUMAN; PRIMARY PREVENTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE;

ANIMALS; ANTIGEN PRESENTATION; ANTIGENS, CD11C; ANTIGENS, CD8; CELL DIFFERENTIATION; CELL PROLIFERATION; DENDRITIC CELLS; FORKHEAD TRANSCRIPTION FACTORS; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; IMMUNOSUPPRESSION; INTERLEUKIN-10; INTERLEUKIN-12; INTERLEUKIN-1BETA; MICE; MICE, SCID; SELF TOLERANCE; T-LYMPHOCYTES, REGULATORY; THYROGLOBULIN; THYROIDITIS, AUTOIMMUNE; VACCINATION;

EID: 61349134275     PISSN: 09538178     EISSN: 14602377     Source Type: Journal    
DOI: 10.1093/intimm/dxn147     Document Type: Article

References (61)

1. Steinman, R. M., Hawiger, D. and Nussenzweig, M. C. 2003. Tolerogenic dendritic cells. Annu. Rev. Immunol. 21:685.
2. Banchereau, J., Briere, F., Caux, C. et al. 2000. Immunobiology of dendritic cells. Annu. Rev. Immunol. 18:767.
3. Schnorrer, P., Behrens, G. M., Wilson, N. S. et al. 2006. The dominant role of CD8+ dendritic cells in cross-presentation is not dictated by antigen capture. Proc. Natl Acad. Sci. USA 103:10729.
4. Maldonado-Lopez, R., Maliszewski, C., Urbain, J. and Moser, M. 2001. Cytokines regulate the capacity of CD8alpha(+) and CD8alpha(-) dendritic cells to prime Th1/Th2 cells in vivo. J. Immunol. 167:4345.
5. Lahoud, M. H., Proietto, A. I., Gartlan, K. H. et al. 2006. Signal regulatory protein molecules are differentially expressed by CD8-dendritic cells. J. Immunol. 177:372.
6. Grohmann, U., Fallarino, F., Bianchi, R. et al. 2001. IL-6 inhibits the tolerogenic function of CD8 alpha+ dendritic cells expressing indoleamine 2,3-dioxygenase. J. Immunol. 167:708.
7. Suss, G. and Shortman, K. 1996. A subclass of dendritic cells kills CD4 T cells via Fas/Fas-ligand-induced apoptosis. J. Exp. Med. 183:1789.
8. Fazekas de St Groth, B. 1998. The evolution of self-tolerance: A new cell arises to meet the challenge of self-reactivity. Immunol. Today 19:448.
9. Hawiger, D., Inaba, K., Dorsett, Y. et al. 2001. Dendritic cells induce peripheral T cell unresponsiveness under steady state conditions in vivo. J. Exp. Med. 194:769.
10. Hawiger, D., Masilamani, R. F., Bettelli, E., Kuchroo, V. K. and Nussenzweig, M. C. 2004. Immunological unresponsiveness characterized by increased expression of CD5 on peripheral T cells induced by dendritic cells in vivo. Immunity 20:695.
11. Bonifaz, L., Bonnyay, D., Mahnke, K., Rivera, M., Nussenzweig, M. C. and Steinman, R. M. 2002. Efficient targeting of protein antigen to the dendritic cell receptor DEC-205 in the steady state leads to antigen presentation on major histocompatibility complex class I products and peripheral CD8+ T cell tolerance. J. Exp. Med. 196:1627.
12. Kretschmer, K., Apostolou, I., Hawiger, D., Khazaie, K., Nussenzweig, M. C. and von Boehmer, H. 2005. Inducing and expanding regulatory T cell populations by foreign antigen. Nat. Immunol. 6:1219.
13. Paul, W. E. and Seder, R. A. 1994. Lymphocyte responses and cytokines. Cell 76:241.
14. Maldonado-Lopez, R., De Smedt, T., Michel, P. et al. 1999. CD8alpha+ and CD8alpha- subclasses of dendritic cells direct the development of distinct T helper cells in vivo. J. Exp. Med. 189:587.
15. O'Shea, J. J. and Paul, W. E. 2002. Regulation of T(H)1 differentiation - controlling the controllers. Nat. Immunol. 3:506.
16. Hochrein, H., Shortman, K., Vremec, D., Scott, B., Hertzog, P. and O'Keeffe, M. 2001. Differential production of IL-12, IFN-alpha, and IFN-gamma by mouse dendritic cell subsets. J. Immunol. 166: 5448.
17. Chtanova, T. and Mackay, C. R. 2001. T cell effector subsets: Extending the Th1/Th2 paradigm. Adv. Immunol. 78:233.
18. Parajuli, P., Mosley, R. L., Pisarev, V. et al. 2001. Flt3 ligand and granulocyte-macrophage colony-stimulating factor preferentially expand and stimulate different dendritic and T-cell subsets. Exp. Hematol. 29:1185.
19. O'Keeffe, M., Hochrein, H., Vremec, D. et al. 2002. Effects of administration of progenipoietin 1, Flt-3 ligand, granulocyte colony-stimulating factor, and pegylated granulocyte-macrophage colony-stimulating factor on dendritic cell subsets in mice. Blood 99:2122.
20. Curti, A., Fogli, M., Ratta, M., Tura, S. and Lemoli, R. M. 2001. Stem cell factor and FLT3-ligand are strictly required to sustain the long-term expansion of primitive CD34+DR- dendritic cell precursors. J. Immunol. 166:848.
21. Kared, H., Masson, A., Adle-Biassette, H., Bach, J. F., Chatenoud, L. and Zavala, F. 2005. Treatment with granulocyte colony-stimulating factor prevents diabetes in NOD mice by recruiting plasmacytoid dendritic cells and functional CD4(+)CD25(+) regulatory T-cells. Diabetes 54:78.
22. Dogan, R. N., Vasu, C., Holterman, M. J. and Prabhakar, B. S. 2003. Absence of IL-4, and not suppression of the Th2 response, prevents development of experimental autoimmune Graves' disease. J. Immunol. 170:2195.
23. Buchsel, P. C., Forgey, A., Grape, F. B. and Hamann, S. S. 2002. Granulocyte macrophage colony-stimulating factor: Current practice and novel approaches. Clin. J. Oncol. Nurs. 6:198.
24. Balducci, L. and Carreca, I. 2002. The role of myelopoietic growth factors in managing cancer in the elderly. Drugs 62(Suppl. 1):47.
25. Sheng, J. R., Li, L., Ganesh, B. B., Vasu, C., Prabhakar, B. S. and Meriggioli, M. N. 2006. Suppression of experimental autoimmune myasthenia gravis by granulocyte-macrophage colony-stimulating factor is associated with an expansion of FoxP3+ regulatory T cells. J. Immunol. 177:5296.
26. Gangi, E., Vasu, C., Cheatem, D. and Prabhakar, B. S. 2005. IL-10-producing CD4+CD25+ regulatory T cells play a critical role in granulocyte-macrophage colony-stimulating factor-induced suppression of experimental autoimmune thyroiditis. J. Immunol. 174:7006.
27. Vasu, C., Dogan, R. N., Holterman, M. J. and Prabhakar, B. S. 2003. Selective induction of dendritic cells using granulocyte macrophage-colony stimulating factor, but not fms-like tyrosine kinase receptor 3-ligand, activates thyroglobulin-specific CD4+/CD25+ Tcells and suppresses experimental autoimmune thyroiditis. J. Immunol. 170:5511.
28. Gaudreau, S., Guindi, C., Menard, M., Besin, G., Dupuis, G. and Amrani, A. 2007. Granulocyte-macrophage colony-stimulating factor prevents diabetes development in NOD mice by inducing tolerogenic dendritic cells that sustain the suppressive function of CD4+CD25+ regulatory T cells. J. Immunol. 179:3638.
29. Esquivel, P. S., Rose, N. R. and Kong, Y. C. 1977. Induction of autoimmunity in good and poor responder mice with mouse thyroglobulin and lipopolysaccharide. J. Exp. Med. 145:1250.
30. Maraskovsky, E., Brasel, K., Teepe, M. et al. 1996. Dramatic increase in the numbers of functionally mature dendritic cells in Flt3 ligand-treated mice: Multiple dendritic cell subpopulations identified. J. Exp. Med. 184:1953.
31. Pulendran, B., Banchereau, J., Burkeholder, S. et al. 2000. Flt3-ligand and granulocyte colony-stimulating factor mobilize distinct human dendritic cell subsets in vivo. J. Immunol. 165:566.
32. Arpinati, M., Green, C. L., Heimfeld, S., Heuser, J. E. and Anasetti, C. 2000. Granulocyte-colony stimulating factor mobilizes T helper 2-inducing dendritic cells. Blood 95:2484.
33. Pulendran, B., Banchereau, J., Maraskovsky, E. and Maliszewski, C. 2001. Modulating the immune response with dendritic cells and their growth factors. Trends Immunol. 22:41.
34. Ganesh, B. B., Cheatem, D. M., Vasu, C. and Prabhakar, B. S. 2007. Induction of peripheral tolerance to treat autoimmune thyroiditis. In Wiersinga, W. M., Drexhage, H. A., Weetman, A. P. and Butz, S., eds, The Thyroid and Autoimmunity. Georg Thieme Verlag, Stuttgart, Germany.17.
35. Cheatem, D. M., Ganesh, B. B., Gangi, E., Vasu, C. and Prabhakar, B. S. 2008. Modulation of dendritic cells using granulocyte-macrophage colony-stimulating factor (GM-CSF) delays type 1 diabetes by enhancing CD4+CD25+ regulatory T cell function. Clin. Immunol. doi:10.1016/ j.clim.2008.12.001.
36. Maldonado-Lopez, R., De Smedt, T., Pajak, B. et al. 1999. Role of CD8alpha+ and CD8alpha- dendritic cells in the induction of primary immune responses in vivo. J. Leukoc. Biol. 66:242.
37. Kalinski, P. and Moser, M. 2005. Consensual immunity: Success-driven development of T-helper-1 and T-helper-2 responses. Nat. Rev. Immunol. 5:251.
38. Morris, G. P., Yan, Y., David, C. S. and Kong, Y. C. 2005. H2A- and H2E-derived CD4+CD25+ regulatory T cells: A potential role in reciprocal inhibition by class II genes in autoimmune thyroiditis. J. Immunol. 174:3111.
39. Verginis, P., Li, H. S. and Carayanniotis, G. 2005. Tolerogenic semimature dendritic cells suppress experimental autoimmune thyroiditis by activation of thyroglobulin-specific CD4+CD25+ T cells. J. Immunol. 174:7433.
40. Morris, G. P. and Kong, Y. C. 2006. Interference with CD4+CD25+ T-cell-mediated tolerance to experimental autoimmune thyroiditis by glucocorticoid-induced tumor necrosis factor receptor monoclonal antibody. J. Autoimmun. 26:24.
41. Morris, G. P., Chen, L. and Kong, Y. C. 2003. CD137 signaling interferes with activation and function of CD4+CD25+ regulatory T cells in induced tolerance to experimental autoimmune thyroiditis. Cell. Immunol. 226:20.
42. O'Sullivan, B. J., Thomas, H. E., Pai, S. et al. 2006. IL-1 beta breaks tolerance through expansion of CD25+ effector T cells. J. Immunol. 176:7278.
43. Brinster, C. and Shevach, E. M. 2008. Costimulatory effects of IL-1 on the expansion/differentiation of CD4+CD25+Foxp3+ and CD4+CD25+Foxp3- T cells. J. Leukoc. Biol. 84:480.
44. Turnquist, H. R., Sumpter, T. L., Tsung, A. et al. 2008. IL-1beta-driven ST2L expression promotes maturation resistance in rapamycin-conditioned dendritic cells. J. Immunol. 181:62.
45. Viglianti, G. A., Lau, C. M., Hanley, T. M., Miko, B. A., Shlomchik, M. J. and Marshak-Rothstein, A. 2003. Activation of autoreactive B cells by CpG dsDNA. Immunity 19:837.
46. Hurst, J. and von Landenberg, P. 2008. Toll-like receptors and autoimmunity. Autoimmun. Rev. 7:204.
47. Zipris, D., Lien, E., Xie, J. X., Greiner, D. L., Mordes, J. P. and Rossini, A. A. 2005. TLR activation synergizes with Kilham rat virus infection to induce diabetes in BBDR rats. J. Immunol. 174:131.
48. Zaccone, P., Fehervari, Z., Blanchard, L., Nicoletti, F., Edwards, C. K. 3rd and Cooke, A. 2002. Autoimmune thyroid disease induced by thyroglobulin and lipopolysaccharide is inhibited by soluble TNF receptor type I. Eur. J. Immunol. 32:1021.
49. Bleich, A., Janus, L. M., Smoczek, A. et al. 2009. CpG motifs of bacterial DNA exert protective effects in mouse models of IBD by antigen-independent tolerance induction. Gastroenterology 136:278.
50. Kwan,W. H., Boix, C., Gougelet, N., Fridman,W. H. and Mueller, C. G. 2007. LPS induces rapid IL-10 release by M-CSF-conditioned tolerogenic dendritic cell precursors. J. Leukoc. Biol. 82:133.
51. Moseman, E. A., Liang, X., Dawson, A. J. et al. 2004. Human plasmacytoid dendritic cells activated by CpG oligodeoxynucleotides induce the generation of CD4+CD25+ regulatory T cells. J. Immunol. 173:4433.
52. Lau, A. W., Biester, S., Cornall, R. J. and Forrester, J. V. 2008. Lipopolysaccharide-activated IL-10-secreting dendritic cells suppress experimental autoimmune uveoretinitis by MHCII-dependent activation of CD62L-expressing regulatory T cells. J. Immunol. 180:3889.
53. Takahashi, T., Kuniyasu, Y., Toda, M. et al. 1998. Immunologic self-tolerance maintained by CD25+CD4+ naturally anergic and suppressive T cells: Induction of autoimmune disease by breaking their anergic/ suppressive state. Int. Immunol. 10:1969.
54. Thornton, A. M. and Shevach, E. M. 1998. CD4+CD25+ immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production. J. Exp. Med. 188:287.
55. Gavin, M. A., Clarke, S. R., Negrou, E., Gallegos, A. and Rudensky, A. 2002. Homeostasis and anergy of CD4(+)CD25(+) suppressor T cells in vivo. Nat. Immunol. 3:33.
56. Hori, S., Haury, M., Coutinho, A. and Demengeot, J. 2002. Specificity requirements for selection and effector functions of CD25 + 4+ regulatory T cells in anti-myelin basic protein T cell receptor transgenic mice. Proc. Natl Acad. Sci. USA 99:8213.
57. Jordan, M. S., Boesteanu, A., Reed, A. J. et al. 2001. Thymic selection of CD4+CD25+ regulatory T cells induced by an agonist self-peptide. Nat. Immunol. 2:301.
58. Apostolou, I., Sarukhan, A., Klein, L. and von Boehmer, H. 2002. Origin of regulatory T cells with known specificity for antigen. Nat. Immunol. 3:756.
59. Roncarolo, M. G., Gregori, S., Battaglia, M., Bacchetta, R., Fleischhauer, K. and Levings, M. K. 2006. Interleukin-10-secreting type 1 regulatory T cells in rodents and humans. Immunol. Rev. 212:28.
60. Wilczynski, J. R., Radwan, M. and Kalinka, J. 2008. The characterization and role of regulatory T cells in immune reactions. Front. Biosci. 13:2266.
61. Bluestone, J. A. and Abbas, A. K. 2003. Natural versus adaptive regulatory T cells. Nat. Rev. Immunol. 3:253.